Schizophrenia Study In Adults

• Status: Completed
• Trial end date: 2003-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A Placebo Controlled Study For Patients With Schizophrenia

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Risperidone

Criteria

Inclusion Criteria:

• Patient must meet diagnostic criteria for schizophrenia.

Exclusion Criteria:

• Patients with other psychotic disorders.

• Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition.

• Patients with a history of autistic disorder or another pervasive developmental disorder.

• Patients with epilepsy or a history of seizures requiring treatment.

• Patients who are excluded from taking the drug risperidone.

• Patients who pose a current serious suicidal or homicidal risk.

• Patients who are adequately stabilized on their treatment.